Inside Drug Pricing - 05/13/2019

Unions, Employers Gear Up To Lobby On Drug-Rebate-Related Policy

By John Wilkerson / May 7, 2019 at 1:03 PM
The pilot CMS is using to artificially lower Medicare Advantage and drug-plan premiums next year will not apply to group MA plans, which means that 4.3 million retired union workers and state and local government employees could be hit with drastically higher premiums if HHS follows through on its proposal to ban drug rebates that aren’t shared at the point of sale. Employers and unions are planning a lobby effort aimed at getting CMS to help so-called employer group waiver...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.